Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer

NCT00316199 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: gemcitabine
DRUG: paclitaxel

Sponsor

Eli Lilly and Company